Screener
10x Genomics, Inc. TXG Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Other receivables | 3,084 | 35,480 |
| Inventory | 52,616 | 56,341 |
| Prepaid expenses and other current assets | 19,393 | 22,208 |
| Total current assets | 674,671 | 684,451 |
| Property and equipment, net | 215,324 | 226,711 |
| Operating lease right-of-use assets | 56,685 | 60,450 |
| Goodwill | 6,918 | 4,511 |
| Intangible assets, net | 61,160 | 62,329 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is 10x Genomics, Inc.'s total current assets?
- 10x Genomics, Inc. (TXG) reported total current assets of $674.67M in Q2 2026.
- How has 10x Genomics, Inc.'s total current assets changed year-over-year?
- 10x Genomics, Inc.'s total current assets increased by 2.9% year-over-year, from $655.66M to $674.67M.
- What is the long-term trend for 10x Genomics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s total current assets has grown at a -2.4% compound annual growth rate (CAGR), from $774.37M to $684.45M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about 10x Genomics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude